Use of neuroimaging in acute stroke trials

References

• Di Carlo A, Launer LJ, Breteler MM et al. Frequency of stroke in Europe: a collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology54(11 Suppl. 5), S28–S33 (2000).
   PubMed Web of Science ®Google Scholar
• Bejot Y, Benatru I, Rouaud O et al. Epidemiology of stroke in Europe: geographic and environmental differences. J. Neurol. Sci.262(1–2), 85–88 (2007).
   PubMed Web of Science ®Google Scholar
• Higashida RT, Furlan AJ, Roberts H et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke34(8), e109–e137 (2003).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA274(13), 1017–1025 (1995).
   PubMed Web of Science ®Google Scholar
• Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke31(4), 811–816 (2000).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med.359(13), 1317–1329 (2008).
   PubMed Web of Science ®Google Scholar
• Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke34(2), 575–583 (2003).
   PubMed Web of Science ®Google Scholar
• The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med.333(24), 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet352(9136), 1245–1251 (1998).
   PubMed Web of Science ®Google Scholar
• Grotta JC, Chiu D, Lu M et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke30(8), 1528–1533 (1999).
   PubMed Web of Science ®Google Scholar
• Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet355(9216), 1670–1674 (2000).
   PubMed Web of Science ®Google Scholar
• Pexman JH, Barber PA, Hill MD et al. Use of the Alberta stroke program early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. Am. J. Neuroradiol.22(8), 1534–1542 (2001).
   PubMed Web of Science ®Google Scholar
• Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke36(10), 2110–2115 (2005).
   PubMed Web of Science ®Google Scholar
• Dzialowski I, Hill MD, Coutts SB et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke37(4), 973–978 (2006).
   PubMedGoogle Scholar
• Hill MD, Rowley HA, Adler F et al. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke34(8), 1925–1931 (2003).
   PubMed Web of Science ®Google Scholar
• Messe SR, Kasner SE, Chalela JA et al. CT-NIHSS mismatch does not correlate with MRI diffusion–perfusion mismatch. Stroke38(7), 2079–2084 (2007)
   PubMedGoogle Scholar
• Kohrmann M, Juttler E, Huttner HB, Nowe T, Schellinger PD. Acute stroke imaging for thrombolytic therapy – an update. Cerebrovasc. Dis.24(2–3), 161–169 (2007).
   PubMedGoogle Scholar
• Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia – the ischemic penumbra. Stroke12(6), 723–725 (1985).
   Google Scholar
• Read SJ, Hirano T, Abbott DF et al. The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann. Neurol.48(2), 228–235 (2000).
   PubMed Web of Science ®Google Scholar
• Maulaz A, Piechowski-Jozwiak B, Michel P, Bogousslavsky J. Selecting patients for early stroke treatment with penumbra images. Cerebrovasc. Dis.20(Suppl. 2), 19–24 (2005).
   PubMedGoogle Scholar
• Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology42(9), 1717–1723 (1992).
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Saver JL, Mattiello J et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology57(11), 2015–2021 (2001).
   PubMedGoogle Scholar
• Kidwell CS, Saver JL, Mattiello J et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann. Neurol.47(4), 462–469 (2000).
   PubMed Web of Science ®Google Scholar
• Takasawa M, Jones PS, Guadagno JV et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke39, 870–877 (2008).
   PubMed Web of Science ®Google Scholar
• Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn. Reson. Med.36(5), 715–725 (1996).
   PubMed Web of Science ®Google Scholar
• Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn. Reson. Med.36(5), 726–736 (1996).
   PubMedGoogle Scholar
• Siemonsen S, Fitting T, Thomalla G et al. T2´ imaging predicts infarct growth beyond the acute diffusion-weighted imaging lesion in acute stroke. Radiology248(3), 979–986 (2008).
   PubMedGoogle Scholar
• Schramm P, Schellinger PD, Fiebach JB et al. Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke33(10), 2426–2432 (2002).
   PubMed Web of Science ®Google Scholar
• Koenig M, Klotz E, Luka B, Venderink DJ, Spittler JF, Heuser L. Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke. Radiology209(1), 85–93 (1998).
   PubMed Web of Science ®Google Scholar
• Wintermark M, Reichhart M, Thiran JP et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann. Neurol.51(4), 417–432 (2002).
   PubMed Web of Science ®Google Scholar
• Sasaki M, Kudo K, Oikawa H. CT perfusion for acute stroke: current concepts on technical aspects and clinical applications. Int. Congr. Ser.1290, 30–36 (2006).
   Google Scholar
• Wintermark M, Meuli R, Browaeys P et al. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology68(9), 694–697 (2007).
   PubMed Web of Science ®Google Scholar
• Heiss WD. Imaging the penumbra: the pathophysiologic basis for therapy of ischemic stroke. Presented at: 10th International Symposium on Thrombolysis and Acute Stroke Therapy. Budapest, Hungary, 21–23 September 2008.
   Google Scholar
• Handschu R, Garling A, Heuschmann PU, Kolominsky-Rabas PL, Erbguth F, Neundorfer B. Acute stroke management in the local general hospital. Stroke32(4), 866–870 (2001).
   PubMed Web of Science ®Google Scholar
• Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology56(8), 1015–1020 (2001).
   PubMed Web of Science ®Google Scholar
• Wintermark M, Albers GW, Alexandrov AV et al. Acute stroke imaging research roadmap. Stroke39(5), 1621–1628 (2008).
   PubMed Web of Science ®Google Scholar
• Wintermark M, Albers GW, Alexandrov AV et al. Acute stroke imaging research roadmap. AJNR Am. J. Neuroradiol.29(5), e23–e30 (2008).
   PubMedGoogle Scholar
• Warach S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr. Control Trials Cardiovasc. Med.2, 38–44 (2001).
   PubMedGoogle Scholar
• Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn. Reson. Med.34(4), 555–566 (1995).
   PubMed Web of Science ®Google Scholar
• Fiehler J, Albers GW, Boulanger JM et al. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke38(10), 2738–2744 (2007).
   PubMed Web of Science ®Google Scholar
• Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood–brain barrier disruption in human focal brain ischemia. Ann. Neurol.56(4), 468–477 (2004).
   PubMed Web of Science ®Google Scholar
• Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke36(10), 2311–2320 (2005).
   PubMed Web of Science ®Google Scholar
• Ritzl A, Meisel S, Wittsack HJ et al. Development of brain infarct volume as assessed by magnetic resonance imaging (MRI): follow-up of diffusion-weighted MRI lesions. J. Magn. Reson. Imaging20(2), 201–207 (2004).
   PubMedGoogle Scholar
• Albers GW, Thijs VN, Wechsler L et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann. Neurol.60(5), 508–517 (2006).
   PubMed Web of Science ®Google Scholar
• Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol.7(4), 299–309 (2008).
   PubMed Web of Science ®Google Scholar
• Ribo M, Molina CA, Rovira A et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke36(3), 602–606 (2005).
   PubMed Web of Science ®Google Scholar
• Schellinger PD, Fiebach JB, Jansen O et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann. Neurol.49(4), 460–469 (2001).
   PubMed Web of Science ®Google Scholar
• Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke36(1), 66–73 (2005).
   PubMed Web of Science ®Google Scholar
• Furlan AJ, Eyding D, Albers GW et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke37(5), 1227–1231 (2006).
   PubMed Web of Science ®Google Scholar
• Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J. Neurol. Neurosurg. Psychiatry78(5), 485–491 (2007).
   PubMedGoogle Scholar
• Kidwell CS, Alger JR, Saver JL. Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke35, 2662–2665 (2004).
   PubMed Web of Science ®Google Scholar